Condition: Breast Cancer · Taxane-Induced Peripheral Neuropathy · Sponsor: Memorial Sloan Kettering Cancer Center
Some people experience a side effect while they are receiving taxane called taxane-induced peripheral neuropathy (TIPN). TIPN is pain in the arms and legs due to nerve damage caused by cancer treatment and may interfere with quality of life. The purpose of this study is to learn if acupuncture can prevent TIPN from getting worse. Acupuncture is a medical technique that involves insertion of very thin needles into specific areas on the body. We will compare real acupuncture (RA) to placebo (sham) acupuncture (SA). SA is done like RA, but will use different needles and target different sites or places on the body than RA. We are comparing RA to SA to learn whether RA can prevent TIPN from getting worse while receiving taxane.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Memorial Sloan Kettering Basking Ridge | Basking Ridge, New Jersey, United States | — |
| Memorial Sloan Kettering Monmouth | Middletown, New Jersey, United States | — |
| Memorial Sloan Kettering Bergen | Montvale, New Jersey, United States | — |
| Memorial Sloan Kettering Suffolk- Commack | Commack, New York, United States | — |
| Memorial Sloan Kettering Westchester | Harrison, New York, United States | — |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | — |
| Memorial Sloan Kettering Nassau | Rockville Centre, New York, United States | — |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.